USP drug classification [BR:br08302]
Cardiovascular Agents
Cardiovascular Agents, Other
Sparsentan
D11776 Sparsentan (USAN/INN)
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
D11776 Sparsentan
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Angiotensin
AGTR1
D11776 Sparsentan (USAN/INN) <US>
Endothelin
EDNRA
D11776 Sparsentan (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11776
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D11776
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11776
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D11776